CAN-204

N/A

Report date: 2024/12/26 11:02:08

Base Information

Drug NameCAN-204
Drug Alias NameCAN-204CAN204
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCanbridge Life Sciences LtdScriptr Global Inc
China Registration ClassN/A

Develop Information

Active CompaniesScriptr Global IncCanbridge Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A